LILRB1 and Miyoshi myopathy: Although the exact roles of SREBPs, which function as transcription factors, and LILRB1, an immune inhibitory receptor, in MM remain unclear, expression of both LILRB1 and SREBPs may decrease the sensitivity of MM cells to ferroptosis by increasing their ability to take up cholesterol [47, 73, 95].